Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2023

Open Access 01-12-2023 | Kidney Cancer | Case report

Kidney cancer with thyroid metastasis combined with thyroid carcinoma, a case report

Authors: Rongli Xie, Dan Tan, Boke Liu, Xujie Han, Xiaoli Jin, Dongjie Shen, Lei Zhou, Jiankang Shen

Published in: BMC Endocrine Disorders | Issue 1/2023

Login to get access

Abstract

Background

Thyroid cancer is the most common malignant tumor of the endocrine system. There have been some reports on kidney cancer with thyroid metastasis. However, kidney cancer has rarely been detected during thyroid cancer surgery.

Case presentation

We present a rare case of kidney cancer with thyroid metastasis, combined with thyroid carcinoma. A 66-year-old woman was admitted to our hospital in September 2021 due to enlarged left thyroid nodules for two years. The patient was diagnosed with a left thyroid nodule on physical examination in 2012. Extended radical resection of the thyroid cancer was performed. Intraoperatively, two thyroid lesions were identified. Thus, the patient was definitively diagnosed with kidney cancer with thyroid metastasis and papillary thyroid carcinoma. Furthermore, two metastatic nodules due to kidney cancer and one metastatic lymph node lesion due to thyroid cancer were found in the loose connective tissue adjacent to the thyroid.

Conclusions

Kidney cancer with thyroid metastasis and thyroid carcinoma rarely co-occur, and it is difficult to identify the primary tumor. Although clinical examination methods are increasingly updated, the past medical history and physical examination are still very important.
Literature
1.
go back to reference Bible KC, Kebebew E, Brierley J, Brito JP, Cabanillas ME, Clark TJ, et al. 2021 American thyroid association guidelines for management of patients with anaplastic thyroid cancer. Thyroid. 2021;31:337–86.CrossRefPubMedPubMedCentral Bible KC, Kebebew E, Brierley J, Brito JP, Cabanillas ME, Clark TJ, et al. 2021 American thyroid association guidelines for management of patients with anaplastic thyroid cancer. Thyroid. 2021;31:337–86.CrossRefPubMedPubMedCentral
3.
go back to reference Jerkovich F, Abelleira E, Bueno F, Guerrero L, Pitoia F. Active Surveillance of small metastatic lymph nodes as an alternative to surgery in selected patients with low-risk papillary thyroid cancer: a retrospective cohort study. Thyroid. 2022;32:1178–83.PubMed Jerkovich F, Abelleira E, Bueno F, Guerrero L, Pitoia F. Active Surveillance of small metastatic lymph nodes as an alternative to surgery in selected patients with low-risk papillary thyroid cancer: a retrospective cohort study. Thyroid. 2022;32:1178–83.PubMed
4.
go back to reference Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1.CrossRefPubMedPubMedCentral Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1.CrossRefPubMedPubMedCentral
5.
go back to reference Kiblut NK, Cussac J-F, Soudan B, Farrell SG, Armstrong JA, Arnalsteen L, et al. Fine needle aspiration and intraparathyroid intact parathyroid hormone measurement for reoperative parathyroid surgery. World J Surg. 2004;28:1143–7.CrossRefPubMed Kiblut NK, Cussac J-F, Soudan B, Farrell SG, Armstrong JA, Arnalsteen L, et al. Fine needle aspiration and intraparathyroid intact parathyroid hormone measurement for reoperative parathyroid surgery. World J Surg. 2004;28:1143–7.CrossRefPubMed
6.
go back to reference Ospina NS, Iñiguez-Ariza NM, Castro MR. Thyroid nodules: diagnostic evaluation based on thyroid cancer risk assessment. BMJ. 2020;368:l6670.CrossRef Ospina NS, Iñiguez-Ariza NM, Castro MR. Thyroid nodules: diagnostic evaluation based on thyroid cancer risk assessment. BMJ. 2020;368:l6670.CrossRef
8.
go back to reference Duggal NM, Horattas M. Metastatic renal cell carcinoma to the thyroid gland. Endocr Pract. 2008;14:1040–6.CrossRefPubMed Duggal NM, Horattas M. Metastatic renal cell carcinoma to the thyroid gland. Endocr Pract. 2008;14:1040–6.CrossRefPubMed
9.
go back to reference Beutner U, Leowardi C, Bork U, Lüthi C, Tarantino I, Pahernik S, et al. Survival after renal cell carcinoma metastasis to the thyroid: single center experience and systematic review of the literature. Thyroid. 2015;25:314–24.CrossRefPubMed Beutner U, Leowardi C, Bork U, Lüthi C, Tarantino I, Pahernik S, et al. Survival after renal cell carcinoma metastasis to the thyroid: single center experience and systematic review of the literature. Thyroid. 2015;25:314–24.CrossRefPubMed
10.
go back to reference Hegerova L, Griebeler ML, Reynolds JP, Henry MR, Gharib H. Metastasis to the thyroid gland: report of a large series from the mayo clinic. Am J Clin Oncol. 2015;38:338–42.CrossRefPubMed Hegerova L, Griebeler ML, Reynolds JP, Henry MR, Gharib H. Metastasis to the thyroid gland: report of a large series from the mayo clinic. Am J Clin Oncol. 2015;38:338–42.CrossRefPubMed
11.
go back to reference Znaor A, Lortet-Tieulent J, Laversanne M, Jemal A, Bray F. International variations and trends in renal cell carcinoma incidence and mortality. Eur Urol. 2015;67:519–30.CrossRefPubMed Znaor A, Lortet-Tieulent J, Laversanne M, Jemal A, Bray F. International variations and trends in renal cell carcinoma incidence and mortality. Eur Urol. 2015;67:519–30.CrossRefPubMed
12.
go back to reference Sindoni A, Rizzo M, Tuccari G, Ieni A, Barresi V, Calbo L, et al. Thyroid metastases from renal cell carcinoma: review of the literature. Sci World J. 2010;10:590–602.CrossRef Sindoni A, Rizzo M, Tuccari G, Ieni A, Barresi V, Calbo L, et al. Thyroid metastases from renal cell carcinoma: review of the literature. Sci World J. 2010;10:590–602.CrossRef
13.
go back to reference Ljungberg B, Albiges L, Abu-Ghanem Y, Bedke J, Capitanio U, Dabestani S, et al. European association of urology guidelines on renal cell carcinoma: the 2022 update. Eur Urol. 2022;82:399–410.CrossRefPubMed Ljungberg B, Albiges L, Abu-Ghanem Y, Bedke J, Capitanio U, Dabestani S, et al. European association of urology guidelines on renal cell carcinoma: the 2022 update. Eur Urol. 2022;82:399–410.CrossRefPubMed
14.
go back to reference Rathmell WK, Rumble RB, Veldhuizen PJV, Al-Ahmadie H, Emamekhoo H, Hauke RJ, et al. Management of metastatic clear cell renal cell carcinoma: ASCO guideline. J Clin Oncol. 2022;40:2957–95.CrossRefPubMed Rathmell WK, Rumble RB, Veldhuizen PJV, Al-Ahmadie H, Emamekhoo H, Hauke RJ, et al. Management of metastatic clear cell renal cell carcinoma: ASCO guideline. J Clin Oncol. 2022;40:2957–95.CrossRefPubMed
Metadata
Title
Kidney cancer with thyroid metastasis combined with thyroid carcinoma, a case report
Authors
Rongli Xie
Dan Tan
Boke Liu
Xujie Han
Xiaoli Jin
Dongjie Shen
Lei Zhou
Jiankang Shen
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2023
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-023-01332-3

Other articles of this Issue 1/2023

BMC Endocrine Disorders 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.